Treating #
CLTI# starts with addressing one of its biggest challenges: vascular calcification.
Because calcium limits vessel compliance and can complicate endovascular treatment, effective calcium modification has become critical to achieving durable outcomes. With its mechanism of action, #
ShockwaveIVL# selectively fractures calcium while minimizing vessel injury, helping optimize treatment across the peripheral vasculature, including below-the-knee interventions with #
ShockwaveE8# on patients with CLTI.
💡Read more in the Vascular News September supplement.
#
CLTI# #
PAD# #
ShockwaveIVL# #
PeripheralIVL# #
VascularHealth# #
MoA# #
JNJMedTechProud#
US Rx only. Safety Info:
Product availability may vary by country.